X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15833) 15833
Newsletter (174) 174
Magazine Article (31) 31
Book Chapter (22) 22
Newspaper Article (14) 14
Transcript (6) 6
Publication (4) 4
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12885) 12885
prednisolone - administration & dosage (9079) 9079
male (8634) 8634
female (8415) 8415
science & technology (7860) 7860
life sciences & biomedicine (7748) 7748
adult (5478) 5478
middle aged (5458) 5458
prednisolone - therapeutic use (4972) 4972
prednisolone (3807) 3807
aged (3480) 3480
treatment outcome (2800) 2800
adolescent (2344) 2344
drug therapy, combination (2314) 2314
animals (2061) 2061
corticosteroids (1857) 1857
antineoplastic combined chemotherapy protocols - therapeutic use (1712) 1712
child (1657) 1657
glucocorticoids - administration & dosage (1643) 1643
cyclophosphamide - administration & dosage (1636) 1636
administration, oral (1629) 1629
prednisolone - adverse effects (1597) 1597
anti-inflammatory agents - administration & dosage (1498) 1498
vincristine - administration & dosage (1452) 1452
glucocorticoids - therapeutic use (1371) 1371
abridged index medicus (1348) 1348
time factors (1333) 1333
anti-inflammatory agents - therapeutic use (1292) 1292
follow-up studies (1228) 1228
prednisolone - pharmacology (1183) 1183
drug administration schedule (1173) 1173
doxorubicin - administration & dosage (1045) 1045
child, preschool (1015) 1015
retrospective studies (951) 951
dose-response relationship, drug (918) 918
oncology (888) 888
immunosuppressive agents - administration & dosage (870) 870
general & internal medicine (848) 848
steroids (846) 846
medicine & public health (840) 840
immunosuppressive agents - therapeutic use (839) 839
remission induction (824) 824
administration, topical (805) 805
prognosis (801) 801
care and treatment (800) 800
hematology (792) 792
rheumatology (786) 786
recurrence (780) 780
medicine, general & internal (775) 775
aged, 80 and over (763) 763
rats (759) 759
diagnosis, differential (712) 712
drug therapy (702) 702
methylprednisolone - administration & dosage (688) 688
pediatrics (684) 684
prospective studies (684) 684
prednisolone - analogs & derivatives (672) 672
dermatology (664) 664
ophthalmology (653) 653
pharmacology & pharmacy (646) 646
combined modality therapy (643) 643
dosage and administration (640) 640
biopsy (637) 637
infant (636) 636
antineoplastic combined chemotherapy protocols - administration & dosage (628) 628
methotrexate - administration & dosage (560) 560
risk factors (557) 557
patients (549) 549
acute disease (545) 545
research (545) 545
analysis (544) 544
young adult (543) 543
surgery (540) 540
double-blind method (526) 526
health aspects (521) 521
glucocorticoids - adverse effects (518) 518
immunology (517) 517
glucocorticoids (507) 507
prednisone - administration & dosage (490) 490
asthma - drug therapy (488) 488
magnetic resonance imaging (476) 476
severity of illness index (476) 476
azathioprine - administration & dosage (474) 474
antineoplastic combined chemotherapy protocols - adverse effects (437) 437
arthritis, rheumatoid - drug therapy (431) 431
tomography, x-ray computed (431) 431
chemotherapy (429) 429
rituximab (426) 426
mice (423) 423
transplantation (417) 417
injections, intravenous (406) 406
cyclophosphamide - therapeutic use (404) 404
gastroenterology & hepatology (404) 404
urology & nephrology (403) 403
chronic disease (402) 402
dexamethasone - administration & dosage (398) 398
cytarabine - administration & dosage (397) 397
kidney transplantation (379) 379
neurosciences & neurology (369) 369
immunosuppressive agents - adverse effects (366) 366
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13087) 13087
Japanese (1988) 1988
German (767) 767
Russian (534) 534
French (155) 155
Spanish (60) 60
Italian (59) 59
Polish (49) 49
Chinese (45) 45
Danish (44) 44
Portuguese (25) 25
Hungarian (20) 20
Norwegian (19) 19
Dutch (18) 18
Swedish (17) 17
Ukrainian (15) 15
Korean (11) 11
Bulgarian (9) 9
Lithuanian (7) 7
Finnish (5) 5
Hebrew (5) 5
Romanian (5) 5
Turkish (4) 4
Croatian (3) 3
Serbian (2) 2
Arabic (1) 1
Czech (1) 1
Greek (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2017, Volume 377, Issue 4, pp. 352 - 360
The addition of abiraterone, a drug that blocks endogenous androgen synthesis, to standard androgen-deprivation therapy in patients with newly diagnosed,... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prednisolone - adverse effects | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prostatic Neoplasms - radiotherapy | Prednisolone - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Abiraterone Acetate - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Prostatic Neoplasms - mortality | Abiraterone Acetate - administration & dosage | Neoplasm Metastasis - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Androgen Antagonists - therapeutic use | Adult | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Prostatic Neoplasms - drug therapy | Androgen suppression therapy | Usage | Prednisone | Research | Prostate cancer | Medical research | Prostate-specific antigen | Clinical trials | Metastasis | Patients | Cancer therapies | Metastases | Androgens | Chemotherapy | Pain | Castration | Medical prognosis | Hypokalemia | Death | Prostate | Index Medicus | Abridged Index Medicus | Abiraterone Acetate/administration & dosage | Prednisolone/administration & dosage | Androgen Antagonists/administration & dosage | Medical and Health Sciences | Medicin och hälsovetenskap | Neoplasm Metastasis/drug therapy | Steroid 17-alpha-Hydroxylase/antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Klinisk medicin | Clinical Medicine | Prostatic Neoplasms/drug therapy | Cancer and Oncology | Cancer och onkologi
Journal Article
The lancet oncology, ISSN 1470-2045, 12/2012, Volume 13, Issue 12, pp. 1250 - 1259
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Evidence-based medicine | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Index Medicus | Abridged Index Medicus | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
Journal Article
Nanomedicine, ISSN 1549-9634, 2015, Volume 11, Issue 5, pp. 1039 - 1046
Journal Article